ARDX News and Press, Ardelyx Inc.

Why The Stock Market Is Down Today Why is the stock market down today? The final week of June and the second quarter has been jam-packed with economic data and inflation-related events. Fed Chair Jerome Powell recently said that the global economy has entered a “new world”...

Ardelyx ( NASDAQ: ARDX ) stated Thursday it has signed a financing deal with HealthCare Royalty Partners to receive up to $20M on the the sale of its future royalties and sales milestones from Kyowa Kirin. Kyowa Kirin is Ardelyx' collaboration partner in Japan fo...

Ardelyx Announces $20 Million Financing Agreement with HealthCare Royalty Partners PR Newswire HealthCare Royalty Partners funding supports the ongoing launch of IBSRELA ® in the United States in exchange for future hyperphosphatemia royalty payments from ...

Ardelyx (NASDAQ:ARDX) said a panel of the U.S. Food and Drug Administration (FDA) will meet in November to discuss an application seeking approval of its for kidney disease drug Xphozah, which was rejected by the regulator last year The FDA's Cardiovascular and Renal Drugs Advisory ...

Ardelyx Announces FDA Advisory Committee Meeting to Review XPHOZAH® NDA Tentatively Scheduled for November 16, 2022 PR Newswire WALTHAM, Mass. , June 21, 2022 /PRNewswire/ -- Ardelyx, Inc. (Nasdaq: ARDX), a biopharmaceutical company founded with a missio...

Ardelyx to Present at the Jefferies 2022 Healthcare Conference PR Newswire WALTHAM, Mass. , June 3, 2022 /PRNewswire/ -- Ardelyx, Inc. (Nasdaq: ARDX), a biopharmaceutical company founded with a mission to discover, develop and commercialize innovative fir...

Ardelyx Presents Data at DDW 2022 on IBSRELA® (tenapanor), a First-In-Class Treatment for IBS-C in Adults PR Newswire Three poster presentations continue to highlight the safety and efficacy of IBSRELA based on data from two Phase 3 trials in adults with irritable...

3 Penny Stocks That Investors Are Buying in May 2022 With May proving to be another interesting month for penny stocks and blue chips, there is a lot that investors need to keep track of. First and foremost, we know that penny stocks are in an extremely volatile place right now. Thi...

Ardelyx Announces Additional Data Supporting the Efficacy and Safety of First-In-Class IBSRELA® (tenapanor) for Adults with IBS-C, to be Presented at DDW 2022 PR Newswire WALTHAM, Mass. , May 17, 2022 /PRNewswire/ -- Ardelyx, Inc. (Nasdaq: ARDX), a biopharma...

Accelerate Diagnostics (NASDAQ:ARDX) is trading 7.2% higher after the company announced on Monday the commercialization of its new Accelerate Arc Module and BC (blood culture) kit for accurate microbial identification for positive blood cultures. The company said the Accel...